SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Lightricks challenges AI giants with open-source text-to-video platform

Full list of Israeli high-tech funding rounds in 2024

TailorMed raises $40 million in equity and debt to help patients access critical medications

Why Israeli tech companies are moving to Miami

Buzz

Most popular

Daily

Weekly

1

Stars over Athens: The who’s who at Calcalist's first Israel-Greece conference

2

Wiz acquires Dazz for $450 million to strengthen AI-driven cloud security

3

Cyera doubles valuation to $3B with $300M Series D, total funding hits $600M in seven months

4

Mediaocean acquires Innovid for $500M, delisting it from the NYSE

5

Claroty veterans launch Twine with $12M in Seed funding from Dell and Wiz founders to deploy AI cyber workers

Helsinn

1 stories about Helsinn

מטה טבע פתח תקווה

Teva's Swiss Anti-Nausea Drug Patent Suit Reaches U.S. Supreme Court

05.12.18|Lilach Baumer

Teva was sued in 2011 by Swiss drug company Helsinn Healthcare over its intention to develop a generic version of Helsin's drug, which it released in the U.S. in March 2018